<DOC>
	<DOCNO>NCT00994981</DOCNO>
	<brief_summary>The purpose study evaluate effect intravenous magnesium infusion reperfusion employ clinical parameter include blood lactate level , intraoperative change blood lactate level hepatic allograft reperfusion serve accurate predictor initial graft function live donor liver transplantation .</brief_summary>
	<brief_title>Magnesium Administration Liver Transplantation Reperfusion Injury</brief_title>
	<detailed_description>Clinically significant hemodynamic deterioration occur immediately reperfusion graft liver unclamping portal vein . Profound hypotension , bradycardia , systemic vasodilation , decrease cardiac output report , described postreperfusion syndrome ( PRS ) . This hemodynamic instability usually require adequate aggressive cardiovascular pharmacologic management fluid support , recovers slowly period 30 60 minutes.Because severity PRS correlate patient allograft outcome , prevention occurrence attenuation hemodynamic change may improve outcome . However , much know protect reperfusion injury . Reperfusion injury also occur myocardial infarction , ischemic spinal cord injury stroke . Recent experiment show protective effect magnesium reduce reperfusion injury condition . Magnesium administration may provide cellular protection ischemia reperfusion stabilize cellular transmembrane potential , suppress excessive cellular calcium influx energy demand .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>adult patient schedule elective living donor liver transplantation pediatric patient retransplantation renal dysfunction cardiovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>magnesium reperfusion injury</keyword>
</DOC>